製品の概要

  • 製品名
    SB 297006
  • 製品の詳細
    Potent, selective CCR3 antagonist
  • 生理活性の詳細
    Highly potent, selective CCR3 antagonist (IC50 = 2.5 μM). Displays 250-fold selectivity for CCR3 vs. CXCR1, CXCR2, CCR1 and CCR7 receptors. Potent inhibitor of Ca2+ mobilization induced by eotaxin, eotaxin-2 and MCP-4 in human eosinophils (IC50 values are 210, 90 and 80 nM, respectively).
  • 精製度
    > 99%

製品の特性

参考文献

This product has been referenced in:
  • Mori A  et al. Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists. Int Immunol 19:913-21 (2007). Read more (PubMed: 17804691) »
  • White JR  et al. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. J Biol Chem 275:36626-31 (2000). Read more (PubMed: 10969084) »

See 1 Publication for this product

レビューと Q&A

There are currently no Customer reviews or Questions for ab120821.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

登録